Latest Period
Q2 2026
Security Snapshot
InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR) Institutional Ownership
CUSIP: 45779A846
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
14
Shares (Excl. Options)
4,216,299
Price
$0.70
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- NSPR on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 4,216,299
- Total 13F value
- $2,951,715
- Portfolio coverage rank
- 0%
- Share change
- +463,371
- Value change
- +$193,204
- Number of holders
- 14
- Shares outstanding
- 48,244,715
- SEC-reported price per share
- $0.70
- Insider filing price
- $0.70
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NSPR - InspireMD, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 45779A846.
- 14 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 34 to 14 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $37,167,726 to $2,951,715.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 14 institutions filings for Q2 2026.
Security key
45779A846
Latest holder period
Q2 2026
13F holders
14
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
NSPR full holder history
InspireMD, Inc. SEC filings
InspireMD, Inc. company facts
InspireMD, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 45779A846:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
NSPR
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 10% | $67,729,915 | 28,103,699 | MARSHALL WACE, LLP | 30 Sep 2025 | |||
| Rosalind Advisors, Inc. | 9.2% | -2.2% | $19,557,045 | 10,987,104 | 0% | Rosalind Advisors, Inc. | 31 Dec 2025 | |
| Nantahala Capital Management, LLC | 10% | 0% | $6,458,327 | +$755,650 | 4,819,647 | +13% | Nantahala Capital Management, LLC | 31 Mar 2026 |
| Lawless Michael A | 8.6% | $8,711,502 | 3,614,731 | Michael A. Lawless | 26 Jun 2025 | |||
| Aberdeen Group plc | 7.5% | +26% | $5,648,588 | +$1,232,200 | 3,173,364 | +28% | Aberdeen Group plc | 31 Dec 2025 |
| ORBIMED ADVISORS LLC | 7.4% | +82% | $5,577,461 | +$1,780,000 | 3,133,405 | +47% | ORBIMED ADVISORS LLC | 31 Dec 2025 |
| Slosman Marvin | 5.2% | $4,167,519 | 2,556,760 | Marvin Slosman | 22 Jan 2026 | |||
| Parkman Healthcare Partners LLC | 5.8% | $5,881,926 | 2,440,633 | Parkman Healthcare Partners LLC | 30 Sep 2025 | |||
| Nantahala Capital Partners Limited Partnership | 5.7% | $5,827,419 | 2,418,016 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 30 Sep 2025 | |||
| Velan Capital Investment Management LP | 5% | -2.2% | $3,146,024 | +$273,469 | 2,347,779 | +9.5% | Velan Capital Master Fund LP | 31 Mar 2026 |
| Shore Craig | 3.5% | $3,577,657 | 1,484,505 | Craig Shore | 26 Jun 2025 |
As of 30 Jun 2026, 14 institutional investors reported holding 4,216,299 shares of InspireMD, Inc. - Common Stock, par value $0.0001 per share (NSPR). This represents 8.7% of the company’s total 48,244,715 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 4,216,299 | $2,951,715 | +$193,204 | $0.70 | 14 |
| 2026 Q1 | 22,802,483 | $37,167,726 | -$616,988 | $1.63 | 34 |
| 2025 Q4 | 23,169,255 | $41,235,253 | -$50,631 | $1.78 | 44 |
| 2025 Q3 | 22,730,210 | $54,778,990 | +$20,913,736 | $2.41 | 40 |
| 2025 Q2 | 14,061,920 | $31,922,818 | +$2,512,314 | $2.27 | 36 |
| 2025 Q1 | 12,917,013 | $34,746,467 | +$554,615 | $2.69 | 34 |
| 2024 Q4 | 12,710,904 | $33,407,511 | +$811,860 | $2.63 | 29 |
| 2024 Q3 | 12,402,374 | $33,215,449 | +$1,209,473 | $2.68 | 27 |
| 2024 Q2 | 11,951,922 | $29,859,952 | +$4,430,429 | $2.50 | 23 |
| 2024 Q1 | 10,178,288 | $23,962,111 | -$399,400 | $2.37 | 25 |
| 2023 Q4 | 10,339,444 | $29,052,785 | +$1,719,804 | $2.81 | 27 |
| 2023 Q3 | 8,762,240 | $28,676,783 | +$2,327,230 | $3.27 | 25 |
| 2023 Q2 | 8,054,251 | $20,221,241 | +$20,007,582 | $2.51 | 22 |
| 2023 Q1 | 88,752 | $103,127 | -$54,760 | $1.12 | 12 |
| 2022 Q4 | 155,809 | $137,173 | +$21,576 | $0.86 | 14 |
| 2022 Q3 | 112,334 | $168,630 | -$78,516 | $1.50 | 11 |
| 2022 Q2 | 129,060 | $256,202 | -$10,358 | $1.99 | 10 |
| 2022 Q1 | 140,275 | $455,524 | -$96,895 | $3.21 | 13 |
| 2021 Q4 | 172,505 | $527,325 | -$27,335 | $3.02 | 15 |
| 2021 Q3 | 170,103 | $703,514 | -$1,360,154 | $4.10 | 12 |
| 2021 Q2 | 450,832 | $2,277,560 | +$2,277,560 | $5.05 | 14 |